Subscriber Authentication Point
lvrea
Home All issues Volume 27 / No 4 (Juillet 2018) Méd. Intensive Réa., 27 4 (2018) 331-343 References
Free Access
Issue
Méd. Intensive Réa.
Volume 27, Number 4, Juillet 2018
Médecine interne et transversalité
Page(s) 331 - 343
Section Article original / Original article
DOI https://doi.org/10.3166/rea-2018-0060
Published online 28 August 2018
  • Casian A, Jayne D, (2011) Management of alveolar hemorrhage in lung vasculitides. Semin Respir Crit Care Med 32: 335–345 [CrossRef] [PubMed] [Google Scholar]
  • Lara AR, Schwarz MI, (2010) Diffuse alveolar hemorrhage. Chest 137: 1164–1171 [CrossRef] [PubMed] [Google Scholar]
  • von Ranke FM, Zanetti G, Hochhegger B, Marchiori E, (2013) Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review. Lung 191: 9–18 [CrossRef] [PubMed] [Google Scholar]
  • Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, Tryfon S, Fervenza FC, Ytterberg SR, Specks U, (2016) Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes. Arthritis Rheumatol 68: 1467–1476 [CrossRef] [PubMed] [Google Scholar]
  • Quadrelli S, Dubinsky D, Solis M, Yucra D, Hernandez M, Karlen H, Brigante A, (2017) Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med 129: 59–62 [CrossRef] [PubMed] [Google Scholar]
  • Benoit FL, Rulon DB, Theil GB, Doolan PD, Watten RH, (1964) Goodpasture’s syndrome: a clinicopathologic entity. Am J Med 37: 424–444 [CrossRef] [Google Scholar]
  • de Prost N, Parrot A, Picard C, Ancel PY, Mayaud C, Fartoukh M, Cadranel J, (2010) Diffuse alveolar hemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J 35: 1303–1311 [CrossRef] [PubMed] [Google Scholar]
  • Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier JF, (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d’études et de recherche sur les maladies « orphelines » pulmonaires (GERM“O”P). Medicine 79: 222–233 [CrossRef] [PubMed] [Google Scholar]
  • Li ZY, Gou SJ, Chen M, Zhao MH, (2013) Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Semin Arthritis Rheum 42: 515–521 [CrossRef] [PubMed] [Google Scholar]
  • Henderson SR, Salama AD, (2018) Diagnostic and management challenges in goodpasture’s (anti-glomerular basement membrane) disease. Nephrol Dial Transplant 33: 196–202 [CrossRef] [PubMed] [Google Scholar]
  • Kimmoun A, Baux E, Das V, Terzi N, Talec P, Asfar P, Ehrmann S, Geri G, Grange S, Anguel N, Demoule A, Moreau AS, Azoulay E, Quenot JP, Boisrame-Helms J, Louis G, Sonneville R, Girerd N, Ducrocq N, Agrinier N, Wahl D, Puechal X, Levy B, (2016) Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Crit Care 20: 27 [Google Scholar]
  • Solans-Laque R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Martinez-Valle F, Saez L, Rios JJ, Solanich X, Oristrell J, Pasquau F, Fonseca E, Zamora M, Callejas JL, Frutos B, Abdilla M, Fanlo P, Garcia-Sanchez I, Lopez-Dupla M, Sopena B, Perez-Iglesias A, Bosch JA; Spanish Registry of systemic vasculitis from the Autoimmune Diseases Study Group of the Spanish Society of Internal Medicine, (2017) Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine 96: e6083 [CrossRef] [PubMed] [Google Scholar]
  • Huart A, Josse AG, Chauveau D, Korach JM, Heshmati F, Bauvin E, Cointault O, Kamar N, Ribes D, Pourrat J, Faguer S; French Society of Hemapheresis, (2016) Outcomes of patients with Goodpasture syndrome: a nationwide cohort-based study from the French Society of Hemapheresis. J Autoimmun 73: 24–29 [CrossRef] [PubMed] [Google Scholar]
  • de Prost N, Parrot A, Cuquemelle E, Picard C, Antoine M, Fleury-Feith J, Mayaud C, Boffa JJ, Fartoukh M, Cadranel J, (2012) Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited. Respir Med 106: 1021–1032 [CrossRef] [PubMed] [Google Scholar]
  • Rabe C, Appenrodt B, Hoff C, Ewig S, Klehr HU, Sauerbruch T, Nickenig G, Tasci S, (2010) Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care 25: 230–235 [CrossRef] [Google Scholar]
  • Chen YB, Guo LC, Yang L, Feng W, Zhang XQ, Ling CH, Ji C, Huang JA, (2010) Angiosarcoma of the lung: 2 cases report and literature reviewed. Lung cancer 70: 352–356 [CrossRef] [PubMed] [Google Scholar]
  • Traclet J, Lazor R, Cordier JF, Cottin V, (2013) Alveolar hemorrhage. Rev Med Interne 34: 214–223 [CrossRef] [PubMed] [Google Scholar]
  • Parrot A, Fartoukh M, Cadranel J, (2015) Alveolar hemorrhage. Rev Mal Respir 32: 394–412 [CrossRef] [PubMed] [Google Scholar]
  • Gibelin A, Maldini C, Mahr A, (2011) Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement. Semin Respir Crit Care Med 32: 264–273 [CrossRef] [PubMed] [Google Scholar]
  • Hirayama K, Kobayashi M, Usui J, Arimura Y, Sugiyama H, Nitta K, Muso E, Wada T, Matsuo S, Yamagata K ; Japanese RSGoPRD, (2015) Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan. Nephrol Dial Transplant 30: i83–93 [CrossRef] [PubMed] [Google Scholar]
  • Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group, (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310–317 [CrossRef] [PubMed] [Google Scholar]
  • Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD, (2004) Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66: 1535–1540 [CrossRef] [PubMed] [Google Scholar]
  • Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM, (1990) Pulmonary Wegener’s granulomatosis. A clinical and imaging study of 77 cases. Chest 97: 906–912 [CrossRef] [PubMed] [Google Scholar]
  • Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK, (2006) Update in the diagnosis and management of pulmonary vasculitis. Chest 129: 452–465 [CrossRef] [PubMed] [Google Scholar]
  • Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taille C, Delaval P, Cadranel J, Bonniaud P, Prevot G, Hirschi S, Gondouin A, Dunogue B, Chatte G, Briault A, Jayne D, Guillevin L, Cordier JF; the Groupe d’études et de recherche sur les maladies orphelines pulmonaires, (2016) Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Eur Respir J 48: 1429–1441 [CrossRef] [PubMed] [Google Scholar]
  • Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier JF, Delaval P, Puechal X, Lauque D, Viallard JF, Zoulim A, Guillevin L, French Vasculitis Study G, (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143: 632–638 [CrossRef] [PubMed] [Google Scholar]
  • Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, Grasselli C, Pavone L, Gregorini G, Monti S, Frassi M, Vecchio F, Corace C, Venegoni E, Buzio C, (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52: 2926–2935 [CrossRef] [PubMed] [Google Scholar]
  • Thompson G, Klecka M, Roden AC, Specks U, Cartin-Ceba R, (2016) Biopsy-proven pulmonary capillaritis: a retrospective study of aetiologies including an in-depth look at isolated pulmonary capillaritis. Respirology 21: 734–738 [CrossRef] [PubMed] [Google Scholar]
  • Lazor R, Bigay-Game L, Cottin V, Cadranel J, Decaux O, Fellrath JM, Cordier JF, (2007) Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine 86: 181–193 [CrossRef] [PubMed] [Google Scholar]
  • Peto P, Salama AD, (2011) Update on antiglomerular basement membrane disease. Curr Opin Rheumatol 23: 32–37 [CrossRef] [PubMed] [Google Scholar]
  • Cui Z, Zhao J, Jia XY, Zhu SN, Zhao MH, (2011) Clinical features and outcomes of anti-glomerular basement membrane disease in older patients. Am J Kidney Dis 57: 575–582 [CrossRef] [PubMed] [Google Scholar]
  • Buret J, Marcq M, Lebranchu Y, Legras A, Barbet C, Mouteaux G, Diot P, (2008) Difficulties in the management of localised pulmonary Goodpasture’s syndrome. Rev Mal Respir 25: 323–327 [CrossRef] [PubMed] [Google Scholar]
  • Legras A, Mordant P, Brechot N, Bel A, Boussaud V, Guillemain R, Cholley B, Gibault L, Le Pimpec-Barthes F, Combes A, (2015) Prolonged extracorporeal membrane oxygenation and lung transplantation for isolated pulmonary anti-GBM (Goodpasture) disease. Intensive Care Med 41: 1866–1868 [CrossRef] [PubMed] [Google Scholar]
  • Sinico RA, Radice A, Corace C, Sabadini E, Bollini B, (2006) Anti-glomerular basement membrane antibodies in the diagnosis of goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 21: 397–401 [CrossRef] [PubMed] [Google Scholar]
  • Ohlsson S, Herlitz H, Lundberg S, Selga D, Molne J, Wieslander J, Segelmark M, (2014) Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. Am J Kidney Dis 63: 289–293 [CrossRef] [PubMed] [Google Scholar]
  • McAdoo SP, Tanna A, Hruskova Z, Holm L, Weiner M, Arulkumaran N, Kang A, Satrapova V, Levy J, Ohlsson S, Tesar V, Segelmark M, Pusey CD, (2017) Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 92: 693–702 [CrossRef] [PubMed] [Google Scholar]
  • Rajagopala S, Shobha V, Devaraj U, D’Souza G, Garg I, (2013) Pulmonary hemorrhage in Henoch-Schönlein purpura: case report and systematic review of the english literature. Semin Arthritis Rheum 42: 391–400 [CrossRef] [PubMed] [Google Scholar]
  • Martinez-Martinez MU, Oostdam DAH, Abud-Mendoza C, (2017) Diffuse alveolar hemorrhage in autoimmune diseases. Curr Rheumatol Rep 19: 27 [CrossRef] [PubMed] [Google Scholar]
  • Ednalino C, Yip J, Carsons SE, (2015) Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: focus on outcome and therapy. J Clin Rheumatol 21: 305–310 [CrossRef] [Google Scholar]
  • Retamozo S, Diaz-Lagares C, Bosch X, Bove A, Brito-Zeron P, Gomez ME, Yague J, Forns X, Cid MC, Ramos-Casals M, (2013) Life-threatening cryoglobulinemic patients with hepatitis C: clinical description and outcome of 279 patients. Medicine 92: 273–284 [CrossRef] [PubMed] [Google Scholar]
  • Yachoui R, Sehgal R, Amlani B, Goldberg JW, (2015) Antiphospholipid antibodies-associated diffuse alveolar hemorrhage. Semin Arthritis Rheum 44: 652–657 [CrossRef] [PubMed] [Google Scholar]
  • Cervera R, Bucciarelli S, Plasin MA, Gomez-Puerta JA, Plaza J, Pons-Estel G, Shoenfeld Y, Ingelmo M, Espinos G; Catastrophic Antiphospholipid Syndrome Registry Project Group, (2009) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun 32: 240–245 [CrossRef] [PubMed] [Google Scholar]
  • Cartin-Ceba R, Peikert T, Ashrani A, Keogh K, Wylam ME, Ytterberg S, Specks U, (2014) Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage. Arthritis Care Res 66: 301–310 [CrossRef] [Google Scholar]
  • Gabrilovich MI, Buxton DE, Lykins DM, McMillen SM, Onadeko OOA, (2014) Diffuse alveolar hemorrhage secondary to apixaban administration. Chest 146: e115–e116 [CrossRef] [PubMed] [Google Scholar]
  • Otoshi T, Kataoka Y, Nakagawa A, Otsuka K, Tomii K, (2016) Clinical features and outcomes of diffuse alveolar hemorrhage during antithrombotic therapy: a retrospective cohort study. Lung 194: 475–481 [CrossRef] [PubMed] [Google Scholar]
  • Moatemri Z, Zaibi H, Dabboussi S, Mhamedi S, Aichaouia C, Khadhraoui M, Cheikh R, (2016) Alveolar hemorrhage following a cannabis water pipe. Rev Pneumol Clin 72: 316–319 [CrossRef] [PubMed] [Google Scholar]
  • Underner M, Perriot J, Wallaert B, Peiffer G, Meurice JC, Jaafari N, (2018) Alveolar hemorrhage and cocaine use. Rev Mal Respir 35: 134–148 [CrossRef] [PubMed] [Google Scholar]
  • Contou D, Voiriot G, Djibre M, Labbe V, Fartoukh M, Parrot A, (2017) Clinical features of patients with diffuse alveolar hemorrhage due to negative-pressure pulmonary edema. Lung 195: 477–487 [CrossRef] [PubMed] [Google Scholar]
  • Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D, Etienne J, (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753–759 [CrossRef] [PubMed] [Google Scholar]
  • Marchiori E, Lourenco S, Setubal S, Zanetti G, Gasparetto TD, Hochhegger B, (2011) Clinical and imaging manifestations of hemorrhagic pulmonary leptospirosis: a state-of-the-art review. Lung 189: 1–9 [CrossRef] [PubMed] [Google Scholar]
  • Niwattayakul K, Kaewtasi S, Chueasuwanchai S, Hoontrakul S, Chareonwat S, Suttinont C, Phimda K, Chierakul W, Silpasakorn S, Suputtamongkol Y, (2010) An open randomized controlled trial of desmopressin and pulse dexamethasone as adjunct therapy in patients with pulmonary involvement associated with severe leptospirosis. Clin Microbiol Infect 16: 1207–1212 [CrossRef] [PubMed] [Google Scholar]
  • Luks AM, Lakshminarayanan S, Hirschmann JV, (2003) Leptospirosis presenting as diffuse alveolar hemorrhage: case report and literature review. Chest 123: 639–643 [CrossRef] [PubMed] [Google Scholar]
  • Venkatram S, Muppuri S, Niazi M, Fuentes GD, (2010) A 24-year-old pregnant patient with diffuse alveolar hemorrhage. Chest 138: 220–223 [CrossRef] [PubMed] [Google Scholar]
  • Ebisawa K, Yamada N, Kobayashi M, Katahira M, Konno H, Okada S, (2013) A cluster of diffuse alveolar hemorrhage cases after the 2011 Tohoku Region Pacific Coast Earthquake. Respir Investig 51: 2–8 [CrossRef] [PubMed] [Google Scholar]
  • Tzouvelekis A, Ntolios P, Oikonomou A, Koutsopoulos A, Sivridis E, Zacharis G, Kaltsas K, Boglou P, Mikroulis D, Bouros D, (2012) Idiopathic pulmonary hemosiderosis in adults: a case report and review of the literature. Case Rep Med 2012: 267857 [CrossRef] [PubMed] [Google Scholar]
  • de Prost N, Parrot A, Cuquemelle E, Picard C, Cadranel J, (2013) Immune diffuse alveolar hemorrhage: a retrospective assessment of a diagnostic scale. Lung 191: 559–563 [CrossRef] [PubMed] [Google Scholar]
  • Pathak V, Kuhn J, Gabriel D, Barrow J, Jennette JC, Henke DC, (2015) Use of activated factor VII in patients with diffuse alveolar hemorrhage: a 10 years institutional experience. Lung 193: 375–379 [CrossRef] [PubMed] [Google Scholar]
  • Pea L, Roda L, Boussaud V, Lonjon B, (2003) Desmopressin therapy for massive hemoptysis associated with severe leptospirosis. Am J Respir Crit Care Med 167: 726–728 [CrossRef] [PubMed] [Google Scholar]
  • HAS, (2007) Vascularites nécrosantes. Protocole national de soins. https://www.has-sante.fr [Google Scholar]
  • Sanders JS, Rutgers A, Stegeman CA, Kallenberg CG, (2011) Pulmonary: renal syndrome with a focus on anti-GBM disease. Semin Respir Crit Care Med 32: 328–334 [CrossRef] [PubMed] [Google Scholar]
  • Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; Group R-IR, (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221–232 [CrossRef] [PubMed] [Google Scholar]
  • Charles P, Bienvenu B, Bonnotte B, Gobert P, Godmer P, Hachulla E, Hamidou M, Harle JR, Karras A, Lega JC, Le Quellec A, Mahr AD, Mouthon L, Papo T, Puechal X, Pugnet G, Samson M, Sibilia J, Terrier B, Vandergheynst F, Guillevin L; FVSG, (2013) Rituximab: recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides. Presse Med 42: 1317–1330 [CrossRef] [PubMed] [Google Scholar]
  • Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcindag N, Jayne DR, Mukhtyar C, (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75: 1583–1594 [CrossRef] [PubMed] [Google Scholar]
  • Clark WF, Huang SS, Walsh MW, Farah M, Hildebrand AM, Sontrop JM, (2016) Plasmapheresis for the treatment of kidney diseases. Kidney Int 90: 974–984 [CrossRef] [PubMed] [Google Scholar]
  • Cui Z, Zhao J, Jia XY, Zhu SN, Jin QZ, Cheng XY, Zhao MH, (2011) Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine 90: 303–311 [CrossRef] [PubMed] [Google Scholar]
  • Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C, Jayne D, (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57: 566–574 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.